TrialJAMA oncology2018

Safety and Efficacy of Pembrolizumab Monotherapy in Patients With Previously Treated Advanced Gastric and Gastroesophageal Junction Cancer: Phase 2 Clinical KEYNOTE-059 Trial.

Charles S Fuchs et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.